Epratuzumab

From WikiMD.org
Jump to navigation Jump to search
Epratuzumab
TermEpratuzumab
Short definitionEpratuzumab (EH-pruh-TOO-zoo-mab) A substance being studied for the treatment of certain types of non-Hodgkin's lymphoma (NHL) and acute lymphoblastic leukemia (ALL). It's also being studied to treat an autoimmune disease called systemic lupus erythematosus (SLE). 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Epratuzumab - (pronounced) (EH-pruh-TOO-zoo-mab) A substance being studied for the treatment of certain types of non-Hodgkin's lymphoma (NHL) and acute lymphoblastic leukemia (ALL). It's also being studied to treat an autoimmune disease called systemic lupus erythematosus (SLE). Epratuzumab attaches to a protein called CD22, which is found on B cells (a type of white blood cell) and some types of cancer cells. This can help suppress the body's immune response and kill cancer cells. Epratuzumab is a type of monoclonal antibody

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski